Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Performance Medicine Institute (PMI) is a specialized healthcare provider focusing on sports medicine, regenerative therapies, and human performance optimization. Led by Dr. Mark Lindsay, the institute provides advanced treatments such as platelet-rich plasma (PRP) and stem cell therapies to address musculoskeletal injuries and chronic pain. PMI integrates physical therapy, metabolic testing, and personalized wellness programs to help elite athletes and high-performance individuals recover and excel. The company operates primarily as a clinical service provider rather than a traditional pharmaceutical developer. Its approach combines manual therapy with biological interventions to accelerate tissue healing and improve functional outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Performance Medicine Institute.